BioCentury | Apr 2, 2021
Management Tracks

BeiGene unveils new CFO; plus Precigen, Alphamab, Flagship, Melinta, Immunome and more

...Corp. (NYSE:MCK), as CCO and Juan Retamero, a computational pathologist, as medical director.Health tech company Color...
...Inc. Alphamab Oncology Ltd. Flagship Pioneering Generate Biomedicines Inc. Atreca Inc. Immunome Inc. Tyme Technologies Inc. Oasmia Pharmaceutical AB AavantiBio Inc. Korro Bio Inc. Paige.AI Inc. Color Beijing...
BioCentury | Mar 22, 2021
Product Development

Genomics plc puts polygenic risk scores to the test with NHS pilot

...contributions of all known risk alleles. The testing approach, which is also being piloted by Color...
BioCentury | Nov 30, 2020
Product Development

Moderna says Warp Speed improved quality, but not speed of its COVID-19 vaccine development

...more than 11,000 volunteers from communities of color...
BioCentury | Nov 23, 2020
Politics, Policy & Law

PhRMA commitment to boosting trial diversity emphasizes community trust and outreach

...with BioCentury. PhRMA called out historic bioethical breaches committed against Black communities and other people of color...
BioCentury | Nov 19, 2020
Product Development

Lucira’s at-home COVID-19 LAMP test breaks barrier, not dam

...studies conducted by FDA, a LAMP test from Color Genomics...
...samples, FDA-authorized LAMP tests developed by Lucira, Color Genomics...
...B round last year. Karen Tkach Tuzman Lucira Health Inc. Color cov19dx at-home...
BioCentury | Nov 18, 2020
Emerging Company Profile

InterVenn: liquid biopsy diagnostics based on glycoproteins

...the problem to underrepresentation of people of color...
BioCentury | Nov 16, 2020
Product Development

Moderna COVID-19 vaccine validates mRNA platform, suggests success of other vaccines

...have been disproportionately impacted by COVID-19.” It enrolled more than 11,000 participants from communities of color...
BioCentury | Oct 3, 2020
Politics, Policy & Law

Congressional Democrats rehearse drug pricing attacks

...with generics “your medication may change shape, color...
BioCentury | Sep 18, 2020
Product Development

Moderna trial recruiting faster than protocol anticipated

...28% of COVE’s participants represented people of color.Moderna...
BioCentury | Sep 16, 2020
Politics, Policy & Law

Vaccine hesitancy: why American values matter. Guest Commentary

...with underlying health conditions and communities of color...
Items per page:
1 - 10 of 305
BioCentury | Apr 2, 2021
Management Tracks

BeiGene unveils new CFO; plus Precigen, Alphamab, Flagship, Melinta, Immunome and more

...Corp. (NYSE:MCK), as CCO and Juan Retamero, a computational pathologist, as medical director.Health tech company Color...
...Inc. Alphamab Oncology Ltd. Flagship Pioneering Generate Biomedicines Inc. Atreca Inc. Immunome Inc. Tyme Technologies Inc. Oasmia Pharmaceutical AB AavantiBio Inc. Korro Bio Inc. Paige.AI Inc. Color Beijing...
BioCentury | Mar 22, 2021
Product Development

Genomics plc puts polygenic risk scores to the test with NHS pilot

...contributions of all known risk alleles. The testing approach, which is also being piloted by Color...
BioCentury | Nov 30, 2020
Product Development

Moderna says Warp Speed improved quality, but not speed of its COVID-19 vaccine development

...more than 11,000 volunteers from communities of color...
BioCentury | Nov 23, 2020
Politics, Policy & Law

PhRMA commitment to boosting trial diversity emphasizes community trust and outreach

...with BioCentury. PhRMA called out historic bioethical breaches committed against Black communities and other people of color...
BioCentury | Nov 19, 2020
Product Development

Lucira’s at-home COVID-19 LAMP test breaks barrier, not dam

...studies conducted by FDA, a LAMP test from Color Genomics...
...samples, FDA-authorized LAMP tests developed by Lucira, Color Genomics...
...B round last year. Karen Tkach Tuzman Lucira Health Inc. Color cov19dx at-home...
BioCentury | Nov 18, 2020
Emerging Company Profile

InterVenn: liquid biopsy diagnostics based on glycoproteins

...the problem to underrepresentation of people of color...
BioCentury | Nov 16, 2020
Product Development

Moderna COVID-19 vaccine validates mRNA platform, suggests success of other vaccines

...have been disproportionately impacted by COVID-19.” It enrolled more than 11,000 participants from communities of color...
BioCentury | Oct 3, 2020
Politics, Policy & Law

Congressional Democrats rehearse drug pricing attacks

...with generics “your medication may change shape, color...
BioCentury | Sep 18, 2020
Product Development

Moderna trial recruiting faster than protocol anticipated

...28% of COVE’s participants represented people of color.Moderna...
BioCentury | Sep 16, 2020
Politics, Policy & Law

Vaccine hesitancy: why American values matter. Guest Commentary

...with underlying health conditions and communities of color...
Items per page:
1 - 10 of 305